163 related articles for article (PubMed ID: 32566150)
1. Collective pharmaceutical procurement in China may have unintended consequences in supply and pricing.
Jiang S; Chen Z; Wu T; Wang H
J Glob Health; 2020 Jun; 10(1):010314. PubMed ID: 32566150
[No Abstract] [Full Text] [Related]
2. Getting new drugs to market: how individuals could do this without leaving their desks.
Collier J
BMJ; 2006 Dec; 333(7582):1315-7. PubMed ID: 17185722
[No Abstract] [Full Text] [Related]
3. Pharmaceutical supply chain in China: current issues and implications for health system reform.
Yu X; Li C; Shi Y; Yu M
Health Policy; 2010 Sep; 97(1):8-15. PubMed ID: 20307912
[TBL] [Abstract][Full Text] [Related]
4. New agreement on branded drugs for the NHS.
Naci H; Dixon J
BMJ; 2019 Jan; 364():l266. PubMed ID: 30658964
[No Abstract] [Full Text] [Related]
5. Pandora's Prescription: The Pharmaceutical Pricing
Pederson T
FASEB J; 2017 Nov; 31(11):4661-4662. PubMed ID: 29093000
[No Abstract] [Full Text] [Related]
6. Drug shortage crisis affects patients and nurses.
Carter D
Am J Nurs; 2011 Nov; 111(11):14. PubMed ID: 22030911
[No Abstract] [Full Text] [Related]
7. Market watch: pricing strategies for emerging markets.
Lineberry N; Snyder E; Gunda S
Nat Rev Drug Discov; 2011 Aug; 10(8):567. PubMed ID: 21804586
[No Abstract] [Full Text] [Related]
8. API Global Sourcing Strategies 2010.
Bennett S
IDrugs; 2010 Sep; 13(9):605-6. PubMed ID: 20799139
[TBL] [Abstract][Full Text] [Related]
9. Access to medicines report cards.
Mullard A
Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
[No Abstract] [Full Text] [Related]
10. Biomanufacturing, from bust to boom...to bubble?
Thiel KA
Nat Biotechnol; 2004 Nov; 22(11):1365-72. PubMed ID: 15529157
[No Abstract] [Full Text] [Related]
11. An audience with...Sir John Sulston.
Sulston J
Nat Rev Drug Discov; 2005 Feb; 4(2):98. PubMed ID: 15756755
[No Abstract] [Full Text] [Related]
12. [Drug shortage--cause and prevention].
Madsen S; Claesson U; Wesenberg GR; Endresen M; Walter AB
Tidsskr Nor Laegeforen; 2012 Oct; 132(19):2154-5. PubMed ID: 23076482
[No Abstract] [Full Text] [Related]
13. Globalization in the pharmaceutical industry, Part I.
Casadio Tarabusi C; Vickery G
Int J Health Serv; 1998; 28(1):67-105. PubMed ID: 9493754
[TBL] [Abstract][Full Text] [Related]
14. Medicines pricing singled out.
Buchanan E
S Afr Med J; 2004 May; 94(5):334. PubMed ID: 15211941
[No Abstract] [Full Text] [Related]
15. Supporting the production of pharmaceuticals in Africa.
Dong J; Mirza Z
Bull World Health Organ; 2016 Jan; 94(1):71-2. PubMed ID: 26769999
[No Abstract] [Full Text] [Related]
16. Pharmaceutical Pricing and Market Access Outlook Europe 2010-HealthNetwork Communications' fourth annual conference. 24-25 March 2010, London, UK.
Ogbighele E
IDrugs; 2010 May; 13(5):317-20. PubMed ID: 20432188
[TBL] [Abstract][Full Text] [Related]
17. [Scientific concept of providing Russian population with drugs].
Nechaev EA
Vestn Ross Akad Med Nauk; 1994; (7):5-10. PubMed ID: 7524855
[No Abstract] [Full Text] [Related]
18. Global "hold-em".
Cassidy BS
Geriatr Nurs; 2006; 27(1):21-3. PubMed ID: 16483897
[No Abstract] [Full Text] [Related]
19. Creating reliable pharmaceutical distribution networks and supply chains in African countries: Implications for access to medicines.
Tetteh E
Res Social Adm Pharm; 2009 Sep; 5(3):286-97. PubMed ID: 19733829
[No Abstract] [Full Text] [Related]
20. Can China bring its own pipeline to the market?
Louët S
Nat Biotechnol; 2004 Dec; 22(12):1497-9. PubMed ID: 15583646
[No Abstract] [Full Text] [Related]
[Next] [New Search]
